STOCK TITAN

[144] GeneDx Holdings Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for GeneDx Holdings Corp. (symbol WGS) documents a proposed sale of 500,000 shares of Class A common stock through Jefferies LLC, with an aggregate market value of $60,451,950 and an approximate sale date of 08/22/2025 on NASDAQ. The filing states the shares were purchased from the issuer on 01/27/2023 for cash. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer. The filing does not name the selling person or provide additional context about ownership or intent.

Avviso Form 144 relativo a GeneDx Holdings Corp. (ticker WGS) segnala una proposta di vendita di 500.000 azioni di categoria A tramite Jefferies LLC, con un valore di mercato complessivo pari a $60.451.950 e una data di vendita approssimativa fissata al 22/08/2025 sul NASDAQ. La comunicazione indica che le azioni sono state acquistate dall'emittente il 27/01/2023 mediante pagamento in contanti. Il dichiarante riporta di non aver venduto titoli negli ultimi tre mesi e include la dichiarazione standard di non essere a conoscenza di informazioni negative rilevanti non divulgate sull'emittente. Il documento non indica il soggetto venditore né fornisce ulteriori dettagli su proprietà o finalità della vendita.

Aviso Formulario 144 para GeneDx Holdings Corp. (símbolo WGS) documenta una propuesta de venta de 500.000 acciones Clase A a través de Jefferies LLC, con un valor de mercado agregado de $60.451.950 y una fecha aproximada de venta el 22/08/2025 en NASDAQ. La presentación indica que las acciones fueron compradas al emisor el 27/01/2023 por efectivo. El declarante informa no haber vendido valores en los últimos tres meses e incluye la representación estándar de no tener conocimiento de información material adversa no divulgada sobre el emisor. La presentación no identifica a la persona vendedora ni ofrece contexto adicional sobre la propiedad o la intención.

GeneDx Holdings Corp. (종목 코드 WGS)에 대한 Form 144 통지는 Jefferies LLC를 통해 클래스 A 보통주 500,000주를 매도하려는 제안을 문서화하고 있으며, 총 시가총액 $60,451,950 및 NASDAQ에서의 예상 매도일을 2025-08-22로 기재하고 있습니다. 제출서류는 해당 주식이 2023-01-27에 발행사로부터 현금으로 매수되었음을 밝힙니다. 신고인은 지난 3개월간 매도한 증권이 없다고 보고하고 있으며, 발행사에 관한 미공개 중대 불리정보를 알지 못한다는 표준 진술을 포함하고 있습니다. 제출서류에는 판매자를 특정하거나 소유권·의도에 관한 추가 맥락은 제공되지 않습니다.

Avis Form 144 concernant GeneDx Holdings Corp. (symbole WGS) signale une proposition de vente de 500 000 actions de catégorie A via Jefferies LLC, d'un valeur marchande totale de 60 451 950 $ et d'une date de vente approximative le 22/08/2025 sur le NASDAQ. Le dépôt indique que les actions ont été achetées auprès de l'émetteur le 27/01/2023 contre paiement en espèces. Le déclarant déclare ne pas avoir vendu de titres au cours des trois derniers mois et inclut la mention standard ne pas être au courant d'informations défavorables matérielles non divulguées concernant l'émetteur. Le dossier ne précise pas la personne vendeuse ni ne fournit de contexte supplémentaire sur la propriété ou l'intention.

Form 144-Mitteilung für GeneDx Holdings Corp. (Ticker WGS) dokumentiert einen geplanten Verkauf von 500.000 Aktien der Klasse A über Jefferies LLC, mit einem gesamten Marktwert von $60.451.950 und einem voraussichtlichen Verkaufstermin am 22.08.2025 an der NASDAQ. Die Einreichung gibt an, dass die Aktien am 27.01.2023 vom Emittenten gegen Bargeld erworben wurden. Der Melder gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und enthält die übliche Erklärung, keine nicht offenbarten wesentlichen nachteiligen Informationen über den Emittenten zu kennen. Die Einreichung nennt nicht die verkaufende Person und liefert keine weiteren Angaben zu Eigentum oder Verkaufsabsicht.

Positive
  • None.
Negative
  • Proposed sale of 500,000 Class A shares is disclosed without identifying the selling individual or entity
  • Filing lacks context on whether the sale is part of a trading plan (e.g., Rule 10b5-1) or ad hoc disposition

Insights

TL;DR: Filing reports a proposed sale of 500,000 Class A shares valued at $60.45M; disclosure lacks seller identity and context.

The Form 144 indicates an intended brokered sale through Jefferies LLC of 500,000 Class A shares on NASDAQ with an aggregate market value of $60,451,950. The shares were acquired from the issuer on 01/27/2023 and paid in cash. The filing does not identify the specific seller or describe whether the sale is part of a pre-arranged trading plan. For investors, the document is a straightforward notice of proposed resale activity but provides limited information to assess insider intent or potential market impact.

TL;DR: Procedural Form 144 filing is compliant in form but omits key identifying details that would clarify regulatory posture.

The notice includes required elements: class of security, broker, number of shares, acquisition date and manner, payment type, and proposed sale date. It also contains the standard attestation regarding material nonpublic information. However, the filing as presented does not show the name of the person on whose account the sale will occur, which limits transparency. From a compliance perspective, the document meets rule-specific content but leaves open questions about aggregation of sales, trading-plan adoption, and potential 10b5-1 reliance.

Avviso Form 144 relativo a GeneDx Holdings Corp. (ticker WGS) segnala una proposta di vendita di 500.000 azioni di categoria A tramite Jefferies LLC, con un valore di mercato complessivo pari a $60.451.950 e una data di vendita approssimativa fissata al 22/08/2025 sul NASDAQ. La comunicazione indica che le azioni sono state acquistate dall'emittente il 27/01/2023 mediante pagamento in contanti. Il dichiarante riporta di non aver venduto titoli negli ultimi tre mesi e include la dichiarazione standard di non essere a conoscenza di informazioni negative rilevanti non divulgate sull'emittente. Il documento non indica il soggetto venditore né fornisce ulteriori dettagli su proprietà o finalità della vendita.

Aviso Formulario 144 para GeneDx Holdings Corp. (símbolo WGS) documenta una propuesta de venta de 500.000 acciones Clase A a través de Jefferies LLC, con un valor de mercado agregado de $60.451.950 y una fecha aproximada de venta el 22/08/2025 en NASDAQ. La presentación indica que las acciones fueron compradas al emisor el 27/01/2023 por efectivo. El declarante informa no haber vendido valores en los últimos tres meses e incluye la representación estándar de no tener conocimiento de información material adversa no divulgada sobre el emisor. La presentación no identifica a la persona vendedora ni ofrece contexto adicional sobre la propiedad o la intención.

GeneDx Holdings Corp. (종목 코드 WGS)에 대한 Form 144 통지는 Jefferies LLC를 통해 클래스 A 보통주 500,000주를 매도하려는 제안을 문서화하고 있으며, 총 시가총액 $60,451,950 및 NASDAQ에서의 예상 매도일을 2025-08-22로 기재하고 있습니다. 제출서류는 해당 주식이 2023-01-27에 발행사로부터 현금으로 매수되었음을 밝힙니다. 신고인은 지난 3개월간 매도한 증권이 없다고 보고하고 있으며, 발행사에 관한 미공개 중대 불리정보를 알지 못한다는 표준 진술을 포함하고 있습니다. 제출서류에는 판매자를 특정하거나 소유권·의도에 관한 추가 맥락은 제공되지 않습니다.

Avis Form 144 concernant GeneDx Holdings Corp. (symbole WGS) signale une proposition de vente de 500 000 actions de catégorie A via Jefferies LLC, d'un valeur marchande totale de 60 451 950 $ et d'une date de vente approximative le 22/08/2025 sur le NASDAQ. Le dépôt indique que les actions ont été achetées auprès de l'émetteur le 27/01/2023 contre paiement en espèces. Le déclarant déclare ne pas avoir vendu de titres au cours des trois derniers mois et inclut la mention standard ne pas être au courant d'informations défavorables matérielles non divulguées concernant l'émetteur. Le dossier ne précise pas la personne vendeuse ni ne fournit de contexte supplémentaire sur la propriété ou l'intention.

Form 144-Mitteilung für GeneDx Holdings Corp. (Ticker WGS) dokumentiert einen geplanten Verkauf von 500.000 Aktien der Klasse A über Jefferies LLC, mit einem gesamten Marktwert von $60.451.950 und einem voraussichtlichen Verkaufstermin am 22.08.2025 an der NASDAQ. Die Einreichung gibt an, dass die Aktien am 27.01.2023 vom Emittenten gegen Bargeld erworben wurden. Der Melder gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und enthält die übliche Erklärung, keine nicht offenbarten wesentlichen nachteiligen Informationen über den Emittenten zu kennen. Die Einreichung nennt nicht die verkaufende Person und liefert keine weiteren Angaben zu Eigentum oder Verkaufsabsicht.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for WGS disclose?

The filing discloses a proposed brokered sale of 500,000 Class A shares through Jefferies LLC with an aggregate market value of $60,451,950 and an approximate sale date of 08/22/2025 on NASDAQ.

When were the shares to be sold by WGS acquired?

The shares were acquired from the issuer on 01/27/2023 and paid for in cash according to the filing.

Does the Form 144 show any securities sold in the past three months for WGS?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is named in the WGS Form 144?

The filing names Jefferies LLC, 520 Madison Avenue, New York, NY 10022 as the broker.

Does the Form 144 indicate any material nonpublic information?

By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
GeneDx Holdings Corp

NASDAQ:WGS

WGS Rankings

WGS Latest News

WGS Latest SEC Filings

WGS Stock Data

3.46B
25.15M
12.46%
110.88%
12.67%
Diagnostics & Research
Services-health Services
Link
United States
STAMFORD